🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT06723418
Active, not recruiting Observational

Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)

NCT06723418 · tracked via the Priya Life Science Germany tracker
Sponsor
University of Glasgow
Phase
Observational
Started
2024-06-15
Last updated
2026-08-11

Condition(s) studied

Inflammatory Bowel Diseases (IBD)Crohns DiseaseUlcerative Colitis (UC)

Investigational drug(s) / intervention(s)

Malnutriton Screening Tool (PYMS)

Malnutriton Screening Tool (PYMS): In a pilot implementation study, PYMS will be used on children with IBD attending the outpatient and inpatient hospital clinics

Study summary

Children with inflammatory bowel disease (IBD) including both Crohn's disease (CD) and ulcerative colitis (UC) can be at high risk of developing malnutrition due to the nature of their condition. It is also believed that some children with IBD, in need of nutritional care, are not identified quickly by their healthcare professionals. This may negatively affect their nutrition, disease progression and general well-being. Hence, it has been proposed that nutritional screening tools or scores (NSTs) should be used to promptly identify children needing further dietetic review and input. Although there are a few NSTs for generic use in sick children at hospital admission, NSTs or scores to use for children with IBD are currently missing. In this study, we would like to test the performance of an existing tool that is routinely used for all sick children at hospital admission (The Paediatric Yorkhill Malnutrition Score or PYMS)(5) and test whether PYMS can detect children with IBD who are at risk of malnutrition. If PYMS doesn't work well, we will develop a specific tool for children with IBD (The Paediatric IBD Nutrition Score or PIBD-NUTS).

Eligibility

Sex
ALL
Min age
4 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Pediatric patients with either Crohn's disease or ulcerative colitis between the ages of (4-18 years) Exclusion Criteria: * Pediatric patients with IBDU

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Salzburg University Hospital Salzburg Austria
Children's Hospital Zagreb Zagreb Croatia
University of Giessen Giessen Germany
Erasmus MC university medical centre Rotterdam Netherlands
The Children's Memorial Health Institute Warsaw Poland
University Hospital Bristol and Weston Bristol United Kingdom
Royal Hospital for Children and Young People Edinburgh United Kingdom
Great Ormond Street Hospital London United Kingdom

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06723418 on ClinicalTrials.gov ↗ ← All trials in Germany